Celera s Online Quandary: Assessing the Unit s Fate as Drug Discovery Beckons | GenomeWeb

NEW YORK, March 5 - When it comes to its online subscription services, Celera, the nascent pharma shop, might soon have to decide whether to fish or cut bait.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.